Literature DB >> 12612069

Activation of the early B-cell-specific mb-1 (Ig-alpha) gene by Pax-5 is dependent on an unmethylated Ets binding site.

Holly Maier1, Jeff Colbert, Daniel Fitzsimmons, Dawn R Clark, James Hagman.   

Abstract

Methylation of cytosine in CpG dinucleotides promotes transcriptional repression in mammals by blocking transcription factor binding and recruiting methyl-binding proteins that initiate chromatin remodeling. Here, we use a novel cell-based system to show that retrovirally expressed Pax-5 protein activates endogenous early B-cell-specific mb-1 genes in plasmacytoma cells, but only when the promoter is hypomethylated. CpG methylation does not directly affect binding of the promoter by Pax-5. Instead, methylation of an adjacent CpG interferes with assembly of ternary complexes comprising Pax-5 and Ets proteins. In electrophoretic mobility shift assays, recruitment of Ets-1 is blocked by methylation of the Ets site (5'CCGGAG) on the antisense strand. In transfection assays, selective methylation of a single CpG within the Pax-5-dependent Ets site greatly reduces mb-1 promoter activity. Prior demethylation of the endogenous mb-1 promoter is required for its activation by Pax-5 in transduced cells. Although B-lineage cells have only unmethylated mb-1 genes and do not modulate methylation of the mb-1 promoter during development, other tissues feature high percentages of methylated alleles. Together, these studies demonstrate a novel DNA methylation-dependent mechanism for regulating transcriptional activity through the inhibition of DNA-dependent protein-protein interactions.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12612069      PMCID: PMC149480          DOI: 10.1128/MCB.23.6.1946-1960.2003

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  46 in total

1.  Structural studies of Ets-1/Pax5 complex formation on DNA.

Authors:  C W Garvie; J Hagman; C Wolberger
Journal:  Mol Cell       Date:  2001-12       Impact factor: 17.970

Review 2.  Methylation matters: modeling a manageable genome.

Authors:  Jared M Ordway; Tom Curran
Journal:  Cell Growth Differ       Date:  2002-04

Review 3.  Methyl CpG binding proteins: coupling chromatin architecture to gene regulation.

Authors:  P A Wade
Journal:  Oncogene       Date:  2001-05-28       Impact factor: 9.867

Review 4.  Specificity of gene regulation.

Authors:  Beverly M Emerson
Journal:  Cell       Date:  2002-05-03       Impact factor: 41.582

5.  DNA methyltransferases get connected to chromatin.

Authors:  Wendy A Burgers; François Fuks; Tony Kouzarides
Journal:  Trends Genet       Date:  2002-06       Impact factor: 11.639

6.  Th2 lineage commitment and efficient IL-4 production involves extended demethylation of the IL-4 gene.

Authors:  Dong U Lee; Suneet Agarwal; Anjana Rao
Journal:  Immunity       Date:  2002-05       Impact factor: 31.745

7.  DNA methyltransferase 3B mutations linked to the ICF syndrome cause dysregulation of lymphogenesis genes.

Authors:  M Ehrlich; K L Buchanan; F Tsien; G Jiang; B Sun; W Uicker; C M Weemaes; D Smeets; K Sperling; B H Belohradsky; N Tommerup; D E Misek; J M Rouillard; R Kuick; S M Hanash
Journal:  Hum Mol Genet       Date:  2001-12-01       Impact factor: 6.150

8.  Control of pre-BCR signaling by Pax5-dependent activation of the BLNK gene.

Authors:  Michael Schebesta; Peter L Pfeffer; Meinrad Busslinger
Journal:  Immunity       Date:  2002-10       Impact factor: 31.745

9.  Highly conserved amino acids in Pax and Ets proteins are required for DNA binding and ternary complex assembly.

Authors:  D Fitzsimmons; R Lutz; W Wheat; H M Chamberlin; J Hagman
Journal:  Nucleic Acids Res       Date:  2001-10-15       Impact factor: 16.971

10.  Gene silencing quantitatively controls the function of a developmental trans-activator.

Authors:  Anne S Hutchins; Alan C Mullen; Hubert W Lee; Kara J Sykes; Frances A High; Brian D Hendrich; Adrian P Bird; Steven L Reiner
Journal:  Mol Cell       Date:  2002-07       Impact factor: 17.970

View more
  38 in total

1.  Epigenomic profiling reveals DNA-methylation changes associated with major psychosis.

Authors:  Jonathan Mill; Thomas Tang; Zachary Kaminsky; Tarang Khare; Simin Yazdanpanah; Luigi Bouchard; Peixin Jia; Abbas Assadzadeh; James Flanagan; Axel Schumacher; Sun-Chong Wang; Arturas Petronis
Journal:  Am J Hum Genet       Date:  2008-03       Impact factor: 11.025

Review 2.  Autoreactive B cells and epigenetics.

Authors:  Yves Renaudineau; Soizic Garaud; Christelle Le Dantec; Ruby Alonso-Ramirez; Capucine Daridon; Pierre Youinou
Journal:  Clin Rev Allergy Immunol       Date:  2010-08       Impact factor: 8.667

Review 3.  T-cell identity and epigenetic memory.

Authors:  Ellen V Rothenberg; Jingli A Zhang
Journal:  Curr Top Microbiol Immunol       Date:  2012       Impact factor: 4.291

Review 4.  B lymphocyte lineage specification, commitment and epigenetic control of transcription by early B cell factor 1.

Authors:  James Hagman; Julita Ramírez; Kara Lukin
Journal:  Curr Top Microbiol Immunol       Date:  2012       Impact factor: 4.291

5.  A recurrent germline PAX5 mutation confers susceptibility to pre-B cell acute lymphoblastic leukemia.

Authors:  Sohela Shah; Kasmintan A Schrader; Esmé Waanders; Andrew E Timms; Joseph Vijai; Cornelius Miething; John T Sandlund; Marshall S Horwitz; Charles G Mullighan; Kenneth Offit; Jeremy Wechsler; Jun Yang; James Hayes; Robert J Klein; Jinghui Zhang; Lei Wei; Gang Wu; Michael Rusch; Panduka Nagahawatte; Jing Ma; Shann-Ching Chen; Guangchun Song; Jinjun Cheng; Paul Meyers; Deepa Bhojwani; Suresh Jhanwar; Peter Maslak; Martin Fleisher; Jason Littman; Lily Offit; Rohini Rau-Murthy; Megan Harlan Fleischut; Marina Corines; Rajmohan Murali; Xiaoni Gao; Christopher Manschreck; Thomas Kitzing; Vundavalli V Murty; Susana Raimondi; Roland P Kuiper; Annet Simons; Joshua D Schiffman; Kenan Onel; Sharon E Plon; David Wheeler; Deborah Ritter; David S Ziegler; Kathy Tucker; Rosemary Sutton; Georgia Chenevix-Trench; Jun Li; David G Huntsman; Samantha Hansford; Janine Senz; Thomas Walsh; Ming Lee; Christopher N Hahn; Kathryn Roberts; Mary-Claire King; Sarah M Lo; Ross L Levine; Agnes Viale; Nicholas D Socci; Katherine L Nathanson; Hamish S Scott; Mark Daly; Steven M Lipkin; Scott W Lowe; James R Downing; David Altshuler
Journal:  Nat Genet       Date:  2013-09-08       Impact factor: 38.330

Review 6.  Mi-2/NuRD chromatin remodeling complexes regulate B and T-lymphocyte development and function.

Authors:  Carissa Dege; James Hagman
Journal:  Immunol Rev       Date:  2014-09       Impact factor: 12.988

7.  Genome-wide association study in Asian populations identifies variants in ETS1 and WDFY4 associated with systemic lupus erythematosus.

Authors:  Wanling Yang; Nan Shen; Dong-Qing Ye; Qiji Liu; Yan Zhang; Xiao-Xia Qian; Nattiya Hirankarn; Dingge Ying; Hai-Feng Pan; Chi Chiu Mok; Tak Mao Chan; Raymond Woon Sing Wong; Ka Wing Lee; Mo Yin Mok; Sik Nin Wong; Alexander Moon Ho Leung; Xiang-Pei Li; Yingyos Avihingsanon; Chun-Ming Wong; Tsz Leung Lee; Marco Hok Kung Ho; Pamela Pui Wah Lee; Yuk Kwan Chang; Philip H Li; Ruo-Jie Li; Lu Zhang; Wilfred Hing Sang Wong; Irene Oi Lin Ng; Chak Sing Lau; Pak Chung Sham; Yu Lung Lau
Journal:  PLoS Genet       Date:  2010-02-12       Impact factor: 5.917

8.  Methylation matters: binding of Ets-1 to the demethylated Foxp3 gene contributes to the stabilization of Foxp3 expression in regulatory T cells.

Authors:  Julia K Polansky; Lisa Schreiber; Christoph Thelemann; Leif Ludwig; Melanie Krüger; Ria Baumgrass; Sascha Cording; Stefan Floess; Alf Hamann; Jochen Huehn
Journal:  J Mol Med (Berl)       Date:  2010-06-24       Impact factor: 4.599

9.  MBD2 and multiple domains of CHD4 are required for transcriptional repression by Mi-2/NuRD complexes.

Authors:  Julita Ramírez; Carissa Dege; Tatiana G Kutateladze; James Hagman
Journal:  Mol Cell Biol       Date:  2012-10-15       Impact factor: 4.272

Review 10.  Immunogenetics of systemic lupus erythematosus: A comprehensive review.

Authors:  Yogita Ghodke-Puranik; Timothy B Niewold
Journal:  J Autoimmun       Date:  2015-08-29       Impact factor: 7.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.